<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.pharmanation.in/news/gst-changes-pharma-inventory-management/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-15T08:24:42.000Z</news:publication_date>
      <news:title>GST Changes Could Benefit Pharma Inventory Management: What Wholesalers and Retailers Need to Know</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/drug-licence-retention-ondls-india/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-15T08:03:23.173Z</news:publication_date>
      <news:title>Drug Licence Compliance in India: ONDLS Integration Could Reduce Paperwork for Pharmacies and Wholesalers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/cancer-medicine-trade-margin-cap-india/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-15T07:49:12.996Z</news:publication_date>
      <news:title>Cancer Medicine Prices in India: Will the 30% Trade-Margin Cap Bring Relief to Patients?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/niper-astrazeneca-clinical-trial-sites-india/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-15T07:34:32.816Z</news:publication_date>
      <news:title>India’s Clinical Research Revolution: NIPER Raebareli and AstraZeneca Join Hands to Strengthen 25 Clinical Trial Sites</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.pharmanation.in/news/biocon-genentech-settlement-pebrilzo-biosimilar-news-2026/</loc>
    <news:news>
      <news:publication><news:name>PharmaNation</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-10-15T07:14:34.706Z</news:publication_date>
      <news:title>Biocon’s Perjeta Biosimilar Deal: A Legal Breakthrough, a Business Opportunity and a Bigger Question for Cancer Care</news:title>
    </news:news>
  </url>
</urlset>
